Therapeutic Advances in Musculoskeletal Disease

Papers
(The TQCC of Therapeutic Advances in Musculoskeletal Disease is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Is there wastage in the research resources for ankylosing spondylitis? An analysis of clinical trial discontinuation and nonpublication outcome95
Anti-sclerostin antibodies: a new frontier in fragility fractures treatment46
The socioeconomic status of patients with ankylosing spondylitis and its association with the burden of the disease and permanent disability: a cross-sectional cluster analysis39
Stakeholder perspectives on musculoskeletal pain assessment and management in the UK: a qualitative study37
An update on the use of conventional and biological disease-modifying anti-rheumatic drugs in hand osteoarthritis31
Mapping emotional function in fibromyalgia: integrating alexithymia, pain catastrophizing, and self-compassion31
Actigraphy-derived physical activity levels and circadian rhythm parameters in patients with psoriatic arthritis: relationship with disease activity, mood, age and BMI31
Serious infection risk in older adults with RA receiving biologic or targeted synthetic DMARDs: the role of age at disease onset30
Drug retention of TNF versus IL-23 inhibitors in psoriatic arthritis: a multicenter real-life cohort study30
Counting the costs: a nationwide study on healthcare use following an adalimumab biosimilar switch in >1300 inflammatory arthritis patients29
Similarities and differences: disentangling the intersection between axial psoriatic arthritis and axial spondyloarthritis27
Patients with poorer health status are more likely to have difficult-to-manage axial spondyloarthritis: insights from a real-world cohort23
Cardio-rheumatology: integrated care and the opportunities for personalized medicine21
The challenge of pharmacotherapy for musculoskeletal pain: an overview of unmet needs20
Reduced bone mineral density in patients with idiopathic inflammatory myopathies: a case-control study18
The association between glucagon-like peptide-1 receptor agonist and rheumatoid arthritis: a population-based case–control study17
Forced vital capacity as a survival predictor in systemic sclerosis-associated pulmonary hypertension16
Recurrent uveitis unveiling axial spondyloarthritis: is inflammatory back pain always the main road to diagnosis? A monocentric cohort15
From advanced imaging to molecular insights: the state of the art in omics for axial spondyloarthritis15
Plain language summary: gout remission with pegloticase15
Dipeptidyl peptidase-4 inhibitors are associated with a lower risk of osteoarthritis in patients with type 2 diabetes14
Early knee OA definition–what do we know at this stage? An imaging perspective14
The association between gout flares and monosodium urate burden assessed using musculoskeletal ultrasound in patients with gout14
T -score discordance between hip and lumbar spine: risk factors and clinical implications13
Effects of acupuncture versus placebo on clinical status and potential specific effects in Fibromyalgia: an umbrella review of 11 meta-analyses13
Role of imaging for eligibility and safety of a-NGF clinical trials13
Intramuscular methylprednisolone administration in hand osteoarthritis patients: a feasibility study to inform a randomized controlled trial13
Age and onset timing of Raynaud’s phenomenon and first non-Raynaud symptom as prognostic factors in systemic sclerosis: a retrospective analysis from the Italian national multicenter Systemic Sclerosi12
Artificial intelligence in Kellgren–Lawrence grading of knee osteoarthritis: bridging radiographic tradition with algorithmic precision12
Development and evaluation of a multivariable prediction model for clinical improvement in an established cohort of Colombian rheumatoid arthritis patients12
Advanced imaging techniques in crystal arthritis11
Systemic lupus erythematosus is associated with increased risk of Parkinson’s disease11
A transfer learning–based approach for automated bone fracture classification in X-ray imaging11
Psoriatic arthritis management: a comparative analysis of PANLAR, EULAR, and GRAPPA treatment recommendations11
Magnetic resonance imaging assessments for knee segmentation and their use in combination with machine/deep learning as predictors of early osteoarthritis diagnosis and prognosis11
Treatment with adalimumab in patients with chronic inflammatory rheumatic diseases: a study of treatment trajectories on a patient level in routine care11
Implementation of clinical decision support tools for treatment selection in knee osteoarthritis: a scoping review11
A novel infrapatellar approach of ultrasound-guided intra-articular injection of the knee from both lateral and medial side: a case series10
Bone marrow edema in children: chronic nonbacterial osteomyelitis and its mimickers10
Gout therapy updated9
Early identification of difficult-to-manage axial spondyloarthritis using machine-learning decision trees9
Mechanisms hypothesized for pain-relieving effects of exercise in fibromyalgia: a scoping review9
Safety, tolerability, and efficacy of the PD-1 agonist antibody JNJ-67484703 in adults with active rheumatoid arthritis: results of a multicenter, double-blind, placebo-controlled, randomized, multipl9
The analysis of the pulmonary domain involvement in Sjögren’s disease9
Precision medicine using molecular-target drugs in psoriatic arthritis8
Towards an individualised approach to pain management in inflammatory arthritis8
Development and validation of a clinical scoring system for the prediction of methotrexate treatment response in rheumatoid arthritis patients: a multicenter real-world study8
Muscle health in ankylosing spondylitis: effects of disease duration, inflammation, education level, and spinal mobility on skeletal muscle atrophy7
Precision medicine in axial spondyloarthritis: current opportunities and future perspectives7
Associations of muscle mass, adipose tissue mass, and skeletal muscle radiodensity with disease activity in axial spondyloarthritis7
Incidence of interstitial lung disease in seropositive rheumatoid arthritis patients receiving biologics, Janus kinase inhibitors, or methotrexate7
Ultrasound evaluation of finger joint cartilage damage progression in patients with rheumatoid arthritis7
Metabolic syndrome and psoriatic arthritis: the role of weight loss as a disease-modifying therapy7
Latest insights in disease-modifying osteoarthritis drugs development6
The application of machine learning in early diagnosis of osteoarthritis: a narrative review6
Effects of adipose-derived mesenchymal stem cell conditioned medium on human tenocytes exposed to high glucose6
Medication holidays in osteoporosis: evidence-based recommendations from the Italian guidelines on ‘Diagnosis, risk stratification, and continuity of care of fragility fractures’ based on a systematic6
Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs)6
Uveitis in patients with axial spondyloarthritis or psoriatic arthritis: a post hoc analysis from placebo-controlled phase III studies with secukinumab6
Achievement of higher thresholds of clinical responses and lower levels of disease activity is associated with improvements in workplace and household productivity in patients with axial spondyloarthr6
Precision imaging biomarkers for gout: artifact-specific spectral CT parameters for personalized differentiation of tophi in a prospective study6
0.032688140869141